Journal Mobile Options
Table of Contents
Vol. 31, No. 4, 2009
Issue release date: June 2009
Dev Neurosci 2009;31:285–292

Prenatal Stress and Neurodevelopment of the Child: Focus on the HPA Axis and Role of the Placenta

O’Donnell K. · O’Connor T.G. · Glover V.
aInstitute of Reproductive and Developmental Biology, Imperial College London, London, UK; bDepartment of Psychiatry, University of Rochester Medical Center, Rochester, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Recent human studies have shown that a wide variety of prenatal stressors, from anxiety and partner relationship problems, to natural disasters, increase the risk for a diverse range of adverse neurodevelopmental outcomes in the child. These include impaired cognitive development and behavioral problems, autism and schizophrenia. However, many questions remain about the underlying processes. Much of the research, based on animal studies, has focussed on the maternal HPA axis, with mixed results. Maternal stress or anxiety during pregnancy has been found to be weakly associated with raised maternal cortisol, if at all. The placenta may be a more promising programming vector, because it controls fetal exposure to the maternal environment. Animal studies indicate that prenatal stress can affect the activity of the placental barrier enzyme 11-βHSD2, which metabolises cortisol. We review the evidence for a similar mechanism in humans and how maternal stress may cause other changes in the placenta which affect fetal neurodevelopment.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry 2008;65:146–152.
  2. Kinney DK, Miller AM, Crowley DJ, Huang E, Gerber E: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord 2008;38:481–488.
  3. Laplante DP, Barr RG, Brunet A, Galbaud du Fort G, Meaney ML, Saucier JF, Zelazo PR, King S: Stress during pregnancy affects general intellectual and language functioning in human toddlers. Pediatr Res 2004;56:400–410.
  4. Laplante DP, Brunet A, Schmitz N, Ciampi A, King S: Project Ice Storm: prenatal maternal stress affects cognitive and linguistic functioning in 5 1/2-year-old children. J Am Acad Child Adolesc Psychiatry 2008;47:1063–1072.
  5. O’Connor TG, Heron J, Golding J, Beveridge M, Glover V: Maternal antenatal anxiety and children’s behavioural/emotional problems at 4 years: report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry 2002;180:502–508.
  6. O’Connor TG, Heron J, Golding J, Glover V: Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry 2003;44:1025–1036.
  7. Huizink AC, Robles de Medina PG, Mulder EJ, Visser GH, Buitelaar JK: Stress during pregnancy is associated with developmental outcome in infancy. J Child Psychol Psychiatry 2003;44:810–818.
  8. DiPietro JA, Novak MF, Costigan KA, Atella LD, Reusing SP: Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev 2006;77:573–587.
  9. Barbazanges A, Vallee M, Mayo W, Day J, Simon H, Le Moal M, Maccari S: Early and later adoptions have different long-term effects on male rat offspring. J Neurosci 1996;16:7783–7790.
  10. Fride E, Soreq H, Weinstock M: Are the effects of gestational stress on motor development and cerebellar cholinesterase activity mediated prenatally? Int J Dev Neurosci 1986;4:407–413.
  11. Clarke AS, Schneider ML: Prenatal stress has long-term effects on behavioral responses to stress in juvenile rhesus monkeys. Dev Psychobiol 1993;26:293–304.
  12. Bergman K, Sarkar P, O’Connor TG, Modi N, Glover V: Maternal stress during pregnancy predicts cognitive ability and fearfulness in infancy. J Am Acad Child Adolesc Psychiatry 2007;46:1454–1463.
  13. Van den Bergh BR, Marcoen A: High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev 2004;75:1085–1097.
  14. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386–389.
  15. Weinstock M: Gender differences in the effects of prenatal stress on brain development and behaviour. Neurochem Res 2007;32:1730–1740.
  16. Salaria S, Chana G, Caldara F, Feltrin E, Altieri M, Faggioni F, Domenici E, Merlo-Pich E, Everall IP: Microarray analysis of cultured human brain aggregates following cortisol exposure: implications for cellular functions relevant to mood disorders. Neurobiol Dis 2006;23:630–636.
  17. Barbazanges A, Piazza PV, Le Moal M, Maccari S: Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 1996;16:3943–3949.
  18. Schneider ML: Growth and development following prenatal stress exposure in primates: an examination of ontogenetic vulnerability. Child Dev 1999;70:263.
  19. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S: Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol 1994;6:341–345.
  20. Kapoor A, Matthews SG: Short periods of prenatal stress affect growth, behaviour and hypothalamo-pituitary-adrenal axis activity in male guinea pig offspring. J Physiol 2005;566:967–977.
  21. Evans LM, Myers MM, Monk C: Pregnant women’s cortisol is elevated with anxiety and depression – but only when comorbid. Arch Womens Ment Health 2008;11:239–248.
  22. Diego MA, Jones NA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Garcia A: Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med 2006;68:747–753.
  23. Sarkar P, Bergman K, Fisk NM, Glover V: Maternal anxiety at amniocentesis and plasma cortisol. Prenat Diagn 2006;26:505–509.
  24. Obel C, Hedegaard M, Henriksen TB, Secher NJ, Olsen J, Levine S: Stress and salivary cortisol during pregnancy. Psychoneuroendocrinology 2005;30:647–656.
  25. Kivlighan KT, DiPietro JA, Costigan KA, Laudenslager ML: Diurnal rhythm of cortisol during late pregnancy: associations with maternal psychological well-being and fetal growth. Psychoneuroendocrinology 2008;33:1225–1235.
  26. Kammerer M, Adams D, Castelberg Bv, Glover V: Pregnant women become insensitive to cold stress. BMC Pregnancy Childbirth 2002;2:8.
  27. Schulte HM, Weisner D, Allolio B: The corticotrophin releasing hormone test in late pregnancy: lack of adrenocorticotrophin and cortisol response. Clin Endocrinol (Oxf) 1990;33:99–106.
  28. de Weerth C, de Wied CCG, Jansen LMC, Buitelaar JK: Cardiovascular and cortisol responses to a psychological stressor during pregnancy. Acta Obstet Gynecol Scand 2007;86:1181–1192.

    External Resources

  29. Davis EP, Glynn LM, Schetter CD, Hobel C, Chicz-Demet A, Sandman CA: Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 2007;46:737–746.
  30. Gutteling BM, de Weerth C, Zandbelt N, Mulder EJ, Visser GH, Buitelaar JK: Does maternal prenatal stress adversely affect the child’s learning and memory at age six? J Abnorm Child Psychol 2006;34:789–798.
  31. Jansson T, Powell TL: Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci 2007;113:1–13.
  32. Gluckman PD, Hanson MA, Spencer HG: Predictive adaptive responses and human evolution. Trends Ecol Evol 2005;20:527–533.
  33. Benediktsson R, Calder AA, Edwards CR, Seckl JR: Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) 1997;46:161–166.
  34. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM: 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998;13:799–804.
  35. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V: Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab 2001;86:104–109.
  36. Holmes MC, Abrahamsen CT, French KL, Paterson JM, Mullins JJ, Seckl JR: The mother or the fetus? 11Beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J Neurosci 2006;26:3840–3844.
  37. Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CR, Jackson AA, Seckl JR: Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 1996;17:169–172.
  38. Langley-Evans SC: Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens 1997;15:537–544.
  39. Welberg LA, Thrivikraman KV, Plotsky PM: Chronic maternal stress inhibits the capacity to up-regulate placental 11beta-hydroxysteroid dehydrogenase type 2 activity. J Endocrinol 2005;186:R7–R12.
  40. Mairesse J, Lesage J, Breton C, Breant B, Hahn T, Darnaudery M, Dickson SL, Seckl J, Blondeau B, Vieau D, Maccari S, Viltart O: Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab 2007;292:E1526–E1533.
  41. Lucassen PJ, Bosch OJ, Jousma E, Kromer SA, Andrew R, Seckl JR, Neumann ID: Prenatal stress reduces postnatal neurogenesis in rats selectively bred for high, but not low, anxiety: possible key role of placental 11beta-hydroxysteroid dehydrogenase type 2. Eur J Neurosci 2009;29:97-103.
  42. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM: Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 2001;86:4979–4983.
  43. Schoof E, Girstl M, Frobenius W, Kirschbaum M, Repp R, Knerr I, Rascher W, Dotsch J: Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. Eur J Endocrinol 2001;145:187–192.
  44. Stewart PM, Whorwood CB, Mason JI: Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol 1995;55:465–471.
  45. Staud F, Mazancova K, Miksik I, Pavek P, Fendrich Z, Pacha J: Corticosterone transfer and metabolism in the dually perfused rat placenta: effect of 11beta-hydroxysteroid dehydrogenase type 2. Placenta 2006;27:171–180.
  46. McCalla CO, Nacharaju VL, Muneyyirci-Delale O, Glasgow S, Feldman JG: Placental 11[beta]-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies. Steroids 1998;63:511–515.
  47. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Bisits AM, Kessell CG, Clifton VL: Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 2003;168:1317–1323.
  48. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Andersson S: Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants. Pediatr Res 2006;59:575–578.
  49. Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K: Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 2008;29:193–200.
  50. White PC: 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 2001;322:308–315.
  51. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Wood PJ, Nuutila M, Andersson S: Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 2003;88:493–500.
  52. Glover V, Bergman K, Sarkar P, O’Connor TG: Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety. Psychoneuroendocrinology 2009;34:430–435.
  53. Wyrwoll CS, Seckl JR, Holmes MC: Altered placental function of 11{beta}-HSD2 knockout mice. Endocrinology 2009;150:1287–1293.
  54. Teixeira JMA, Fisk NM, Glover V: Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 1999;318:153–157.
  55. Sjostrom K, Valentin L, Thelin T, Marsal K: Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997;74:149–155.
  56. Kent A, Hughes P, Ormerod L, Jones G, Thilaganathan B: Uterine artery resistance and anxiety in the second trimester of pregnancy. Ultrasound Obstet Gynecol 2002;19:177–179.
  57. Rodriguez A, Bohlin G: Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry 2005;46:246–254.
  58. van den Bergh BR, Mennes M, Stevens V, van der Meere J, Borger N, Stiers P, Marcoen A, Lagae L: ADHD deficit as measured in adolescent boys with a continuous performance task is related to antenatal maternal anxiety. Pediatr Res 2006;59:78–82.
  59. Van den Bergh BRH, Van Calster B, Smits T, Van Huffel S, Lagae L: Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008;33:536–545.
  60. Gutteling BM, de Weerth C, Willemsen-Swinkels SH, Huizink AC, Mulder EJ, Visser GH, Buitelaar JK: The effects of prenatal stress on temperament and problem behavior of 27-month-old toddlers. Eur Child Adolesc Psychiatry 2005;14:41–51.
  61. Hernandez-Reif M, Field T, Diego M, Ruddock M: Greater arousal and less attentiveness to face/voice stimuli by neonates of depressed mothers on the Brazelton Neonatal Behavioral Assessment Scale. Infant Behav Dev 2006;29:594–598.
  62. Huizink AC, Dick DM, Sihvola E, Pulkkinen L, Rose RJ, Kaprio J: Chernobyl exposure as stressor during pregnancy and behaviour in adolescent offspring. Acta Psychiatr Scand 2007;116:438–446.
  63. Brand SR, Engel SM, Canfield RL, Yehuda R: The effect of maternal PTSD following in utero trauma exposure on behavior and temperament in the 9-month-old infant. Ann NY Acad Sci 2006;1071:454–458.

Pay-per-View Options
Direct payment This item at the regular price: USD 9.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 8.00